Module 4 of 5
In Progress

Module 4: Genetic dyslipidaemias diagnosis and treatment

Lucas Blomgren November 1, 2022

Speaker: Robert Hegele, London, Ontario, Canada

About the talk:

The human genome project has allowed reclassification of genetic dyslipidemias – including hypercholesterolemia and hypertriglyceridemia – providing a framework for diagnostic next-generation sequencing. 

About the speaker:

Rob Hegele is a Distinguished Professor of Medicine and Biochemistry at Western University in London, Ontario, Canada.   He cares for >2500 patients in his lipid clinic.  His laboratory discovered the genes that cause >20 human diseases.  He was among the first in the world to use five medications that are now routinely prescribed to treat dyslipidemia or diabetes.  He has published >870 papers, and is in the top 1% of highly cited scientists in the world.  The website Expertscape.com in 2022 ranked him #1 globally in the area of “hypertriglyceridemia” and #2 for “disorders of lipid metabolism”.   He received the 2019 American Heart Association Lyman Duff Award and the 2020 FH Foundation Pioneer Award.   He has co-authored many clinical practice guidelines for cholesterol, blood pressure and diabetes. He has trained numerous physicians, medical students and graduate students.

Module Content
0% Complete 0/2 Steps